A new Research Triangle company, Persistence Therapeutics, is developing a small, implantable device that generates and delivers genetically engineered T cells directly inside the body. These cells, ...

A new Research Triangle company, Persistence Therapeutics, is developing a small, implantable device that generates and delivers genetically engineered T cells directly inside the body. These cells, ...

The GXP site feeds into a surge of biomanufacturing activity in the state’s Eastern Region. The region scored $7.1 billion of ...

"Deepening our relationship with Wake Forest University School of Medicine validates applications for medical foods, adds depth and capability to the PBI team, and accelerates sales through faster ...

The recently passed federal defense budget for 2026 includes dedicated funding for the use of bioengineered blood vessels ...

The Translational Research Grant (TRG) program funds research projects that explore commercial applications or initiate the early commercial development of university-held life sciences inventions.

Life sciences companies from around the globe continued to favor North Carolina for both new sites and expanded operations in ...

Join Innovate Carolina and NCBiotech for a comprehensive seminar highlighting NCBiotech's robust support services that fuel North Carolina's life sciences ecosystem. Whether you're an academic ...

AskBio Inc., an RTP-based gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG, has received U.S. Food and Drug Administration (FDA) acceptance of its ...

This event brings together pharmaceutical and biopharmaceutical professionals—from students and emerging leaders to senior executives in drug manufacturing, supply chain, devices, services, and ...

Sponsored by the Biomanufacturing Training and Education Center (BTEC) at NC State University, this career fair is open to anyone interested in biomanufacturing, biotechnology, and life sciences. NC ...

Curious about how Australia emerged as a leading destination for clinical trials? Attend this event to discover how Australian Advantage can accelerate early-phase clinical trials.